Ars Pharmaceuticals, Inc. [SBTX]

Source: 

Company Overview

Ars Pharmaceuticals, Inc is a biopharmaceutical company focused on the development of our novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an innovative absorption enhancer called Intravail , which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.